AI, 3D Imaging to Drive Mammography Market Growth Throughout 2030

The global mammography equipment market is projected to expand from US$3.1 billion in 2025 to US$4 billion by 2030, growing at a compound annual rate of 5.2%, according to a new study by BCC Research. North America, including Mexico, holds the largest market share, followed by the European Union and Asia-Pacific. 

“AI-powered diagnostics, 3D imaging, and advanced techniques like CE DE Mammography and Molecular Breast Imaging are transforming breast cancer detection, driving demand for faster, safer, and more personalized screening solutions,” reads the report.

The study attributes growth primarily to the rising global incidence of breast cancer, wider adoption of mammography screening, and technological innovations that enhance diagnostic accuracy. According to GLOBOCAN 2024, 2.3 million new breast cancer cases were detected worldwide, making up nearly 12% of all cancer diagnoses, and caused 665,684 deaths. 

Digital mammography systems are expected to remain the dominant product category through 2030, particularly full-field digital mammography, digital breast tomosynthesis, and contrast-enhanced systems. The analysis also highlights increasing demand for portable and mobile mammography units, designed to expand access in underserved areas. These systems are considered to be essential to outreach programs that address disparities in cancer screening.

Advances in AI are playing a central role in market growth. FDA-approved platforms such as iCAD’s ProFound AI and Hologic’s Genius AI Detection 2.0 now assist radiologists by identifying suspicious areas independently, which can increase detection rates and reduce reading time by as much as 50%. Startups are also contributing to innovation: Therapixel’s MammoScreen, which scores mammograms to flag potential abnormalities, and Vara’s workflow-integrated platform, now deployed in Mexico and India, are examples of how AI tools are becoming embedded in clinical practice.

Despite growth drivers, the study cites challenges including radiation safety concerns and a shortage of radiologists, as staffing constraints could limit screening capacity.

Key companies in the sector include GE Healthcare, Siemens Healthineers, Fujifilm Holdings, Canon, Philips, and Hologic, along with specialized manufacturers such as Planmed Oy, Italray, and Metaltronica.